Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd (FTRP)

Field Trip Health Ltd (FTRP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,023
  • Shares Outstanding, K 58,215
  • Annual Sales, $ 3,880 K
  • Annual Income, $ -43,630 K
  • 60-Month Beta N/A
  • Price/Sales 12.51
  • Price/Cash Flow N/A
  • Price/Book 0.92
Trade FTRP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings $-0.20 on 06/29/22
  • Latest Earnings Date 08/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.15
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7803 +7.92%
on 08/02/22
0.9750 -13.63%
on 07/20/22
+0.0022 (+0.26%)
since 07/15/22
3-Month
0.7400 +13.80%
on 06/23/22
0.9950 -15.37%
on 05/18/22
-0.0913 (-9.78%)
since 05/16/22
52-Week
0.7100 +18.61%
on 05/10/22
6.4100 -86.86%
on 10/19/21
-4.1679 (-83.19%)
since 08/16/21

Most Recent Stories

More News
Field Trip Health Ltd. (FTRP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Field Trip Health Ltd. (FTRP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FTRP : 4.2105 (+1.07%)
MTEM : 1.7800 (-5.82%)
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange

– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022....

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

CYBN.NE : 0.5100 (+2.00%)
SILO : 1.9000 (-3.55%)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
ATAI : 2.07 (-10.00%)
CYBN : 0.3708 (+1.31%)
ENBI.CN : 0.1400 (+7.69%)
ENTBF : 0.1199 (+55.92%)
CMPS : 8.32 (-3.93%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

/PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many...

ENTBF : 0.1199 (+55.92%)
FTRP.TO : 1.09 (+5.83%)
SILO : 1.9000 (-3.55%)
FTRP : 4.2105 (+1.07%)
ATAI : 2.07 (-10.00%)
CYBN : 0.3708 (+1.31%)
CMPS : 8.32 (-3.93%)
Field Trip Announces First Dosings in Phase I Clinical Study of FT-104

- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation Ratio ...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization

Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies

- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting

Approves spin-out of clinics business to Field Trip Health & Wellness Ltd., pending final court approval and additional customary closing conditions...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting

Approves spin-out of clinics business to Field Trip Health & Wellness Ltd., pending final court approval and additional customary closing conditions...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022

TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.0050 (unch)
FTRP : 4.2105 (+1.07%)
FTRP.TO : 1.09 (+5.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Field Trip Health Ltd. is involved in the development and delivery of psychedelic therapies. Field Trip Health Ltd. is based in TORONTO.

See More

Key Turning Points

3rd Resistance Point 0.8928
2nd Resistance Point 0.8714
1st Resistance Point 0.8568
Last Price 4.2105
1st Support Level 0.8208
2nd Support Level 0.7994
3rd Support Level 0.7848

See More

52-Week High 6.4100
Fibonacci 61.8% 4.2326
Last Price 4.2105
Fibonacci 50% 3.5600
Fibonacci 38.2% 2.8874
52-Week Low 0.7100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar